The Valley Desk

NCT04489888 · Interventional trial

A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)

Overall registry status Completed

Phase 4

Conditions Squamous Cell Carcinoma of Head and Neck

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov